journal article·2022-12-14Open access

Single Low-Dose Nanovaccine for Long-Term Protection against Anthrax Toxins

Maya Holay, Nishta Krishnan, Jiarong Zhou, Yaou Duan, Zhongyuan Guo, Weiwei Gao, Ronnie H. Fang, Liangfang Zhang

Nano Letters· Volume 22· Issue 23

Abstract

Anthrax infections caused by Bacillus anthracis are an ongoing bioterrorism and livestock threat worldwide. Current approaches for management, including extended passive antibody transfusion, antibiotics, and prophylactic vaccination, are often cumbersome and associated with low patient compliance. Here, we report on the development of an adjuvanted nanotoxoid vaccine based on macrophage membrane-coated nanoparticles bound with anthrax toxins. This design leverages the natural binding interaction of protective antigen, a key anthrax toxin, with macrophages. In a murine model, a single low-dose vaccination with the nanotoxoids generates long-lasting immunity that protects against subsequent challenge with anthrax toxins. Overall, this work provides a new approach to address the ongoing threat of anthrax outbreaks and bioterrorism by taking advantage of an emerging biomimetic nanotechnology.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bacillus and Francisella bacterial research · Bacteriophages and microbial interactions · Viral Infections and Outbreaks Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of NanoEngineering, Chemical Engineering Program, and Moores Cancer Center, University of California, San Diego, La Jolla, California 92093, United States

Funding

National Institute of Allergy and Infectious Diseases · Defense Threat Reduction Agency

References (59)

Show source-provided references
1. 10.1038/s41564-019-0435-410.1038/s41564-019-0435-4 ↗
2. 10.1016/S0736-4679(03)00079-910.1016/S0736-4679(03)00079-9 ↗
3. 10.1146/annurev-micro-091014-10452310.1146/annurev-micro-091014-104523 ↗
4. 10.1080/14712598.2020.180162610.1080/14712598.2020.1801626 ↗
5. 10.1073/pnas.163198310010.1073/pnas.1631983100 ↗
6. 10.3390/toxins308100410.3390/toxins3081004 ↗
7. 10.1016/j.tim.2014.02.01210.1016/j.tim.2014.02.012 ↗
8. 10.1016/j.chom.2010.10.00410.1016/j.chom.2010.10.004 ↗
9. 10.32607/actanaturae.1138710.32607/actanaturae.11387 ↗
10. 10.1146/annurev.cellbio.19.111301.14065510.1146/annurev.cellbio.19.111301.140655 ↗
11. 10.1080/14760584.2016.125455610.1080/14760584.2016.1254556 ↗
12. 10.1016/S0264-410X(02)00166-410.1016/S0264-410X(02)00166-4 ↗
13. 10.1002/jps.2342210.1002/jps.23422 ↗
14. 10.1016/j.vaccine.2018.09.01210.1016/j.vaccine.2018.09.012 ↗
15. 10.1016/j.vaccine.2011.05.04710.1016/j.vaccine.2011.05.047 ↗
16. 10.1196/annals.1348.03010.1196/annals.1348.030 ↗
17. 10.1586/14760584.5.3.36510.1586/14760584.5.3.365 ↗
18. 10.1016/j.carbpol.2020.11604110.1016/j.carbpol.2020.116041 ↗
19. 10.3389/fimmu.2018.0056210.3389/fimmu.2018.00562 ↗
20. 10.1002/adma.20170675910.1002/adma.201706759 ↗
21. 10.1016/j.biomaterials.2017.02.04110.1016/j.biomaterials.2017.02.041 ↗
22. 10.1038/nature1537310.1038/nature15373 ↗
23. 10.1021/nl500618u10.1021/nl500618u ↗
24. 10.1021/nl504798g10.1021/nl504798g ↗
25. 10.1039/C9NH00291J10.1039/C9NH00291J ↗
26. 10.7150/thno.3721610.7150/thno.37216 ↗
27. 10.1038/s41571-022-00699-x10.1038/s41571-022-00699-x ↗
28. Wang S. · Adv. Mater. · 2022 · 34 · e210771910.1002/adma.202107719 ↗
29. 10.1016/j.addr.2015.04.00110.1016/j.addr.2015.04.001 ↗
30. 10.1002/adbi.20180021910.1002/adbi.201800219 ↗
31. 10.1002/adma.20190125510.1002/adma.201901255 ↗
32. 10.1002/adtp.20210007210.1002/adtp.202100072 ↗
33. 10.1038/nnano.2013.5410.1038/nnano.2013.54 ↗
34. 10.1038/s41565-018-0254-410.1038/s41565-018-0254-4 ↗
35. 10.1021/acs.nanolett.0c0227810.1021/acs.nanolett.0c02278 ↗
36. 10.1038/nnano.2013.25410.1038/nnano.2013.254 ↗
37. 10.1021/acs.nanolett.8b0505110.1021/acs.nanolett.8b05051 ↗
38. 10.1021/acs.nanolett.9b0184410.1021/acs.nanolett.9b01844 ↗
39. 10.1021/acs.nanolett.2c0194810.1021/acs.nanolett.2c01948 ↗
40. 10.1093/infdis/jiac07410.1093/infdis/jiac074 ↗
41. 10.1002/adma.20170396910.1002/adma.201703969 ↗
42. 10.1038/s41598-017-03253-310.1038/s41598-017-03253-3 ↗
43. 10.1038/385833a010.1038/385833a0 ↗
44. 10.1074/jbc.M40129220010.1074/jbc.M401292200 ↗
45. 10.1038/nri132910.1038/nri1329 ↗
46. 10.7150/thno.4122810.7150/thno.41228 ↗
47. 10.1021/acs.nanolett.9b0517110.1021/acs.nanolett.9b05171 ↗
48. 10.2147/IJN.S24149210.2147/IJN.S241492 ↗
49. 10.1146/annurev.biochem.75.103004.14272810.1146/annurev.biochem.75.103004.142728 ↗
50. 10.1111/j.1600-0854.2009.00899.x10.1111/j.1600-0854.2009.00899.x ↗
51. 10.4049/jimmunol.178.5.264610.4049/jimmunol.178.5.2646 ↗
52. 10.4049/jimmunol.090158110.4049/jimmunol.0901581 ↗
53. 10.1128/CVI.00324-1210.1128/CVI.00324-12 ↗
54. 10.4049/jimmunol.170.11.563610.4049/jimmunol.170.11.5636 ↗
55. 10.1111/j.1574-695X.2001.tb00535.x10.1111/j.1574-695X.2001.tb00535.x ↗
56. 10.1128/IAI.69.5.2888-2893.200110.1128/IAI.69.5.2888-2893.2001 ↗
57. 10.1002/adma.20200180810.1002/adma.202001808 ↗
58. 10.1126/sciadv.abf782010.1126/sciadv.abf7820 ↗
59. 10.1002/anie.20211367110.1002/anie.202113671 ↗